WEST CHESTER, Ohio — Veo Ophthalmics has entered into a strategic partnership with PeriVision, allowing them to launch the VisionOne AI visual field platform in the U.S. The VisionOne utilizes PeriVision’s patented AI visual field-testing algorithm (SORS) to optimize visual field tests, increasing efficiency and accuracy while decreasing testing time.
With VisionOne, ECPs can perform visual field tests on portable VR headsets and subsequently analyze the results on a cloud platform. AI algorithms optimize the eye tests, automate assistance and quality control.
At the core of the VisionOne lies PeriVision’s patented visual field-testing algorithm SORS (Sequentially Optimized Reconstruction Strategy). VisionOne addresses the clinical need for more efficient and patient-friendly visual field testing, a routine eye test for glaucoma diagnosis and monitoring. In clinical studies it has demonstrated the ability to reduce test time dramatically, while maintaining high correlation with the gold standard and lower test/re-test variability.
“Just last year, a publication estimated that from 2020 to 2035, the ophthalmology workforce is expected to shrink by more than 2600 full-time equivalent (FTE), while demand will grow by around 5000 FTE,” said Patrick Kessel, CEO of PeriVision. “VisionOne addresses this drastically growing need for more efficient and patient-friendly ophthalmic testing. We are very excited to partner with VEO Ophthalmics to deliver our breakthrough technology to eye care professionals across the U.S.”
Ron Gilliland, President and CEO of VEO Ophthalmics, added, “VisionOne uniquely allows eye care professionals to reduce visual field testing time and maintain accuracy when diagnosing and monitoring glaucoma with advanced AI algorithms. We are very pleased to partner with PeriVision and bring this technology to eye care professionals to enhance patient care.”
To learn more, visit VEO at www.veo-ophthalmics.com
Author
